The Role of Amino-Terminal Sequences in Cellular Localization and Antiviral Activity of APOBEC3B

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Virology

• Publication date

  2011-06-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.02645-10PMID 21715505PMCID PMC3165795
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction

  2010cited by this paper
• Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics

  2010cited by this paper
• No evidence of an association between the APOBEC3B deletion polymorphism and susceptibility to HIV infection and AIDS in Japanese and Indian populations.

  2010cited by this paper
• APOBEC3F and APOBEC3G Inhibit HIV-1 DNA Integration by Different Mechanisms

  2010cited by this paper
• Defining APOBEC3 Expression Patterns in Human Tissues and Hematopoietic Cell Subsets

  2009cited by this paper
• HIV-1 Vif-mediated ubiquitination/degradation of APOBEC3G involves four critical lysine residues in its C-terminal domain

  2009cited by this paper
• Likely Role of APOBEC3G-Mediated G-to-A Mutations in HIV-1 Evolution and Drug Resistance

  2009cited by this paper
• APOBEC3 Proteins Inhibit LINE‐1 Retrotransposition in the Absence of ORF1p Binding

  2009cited by this paper
• Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA

  2009cited by this paper
• APOBEC3G induces a hypermutation gradient: purifying selection at multiple steps during HIV-1 replication results in levels of G-to-A mutations that are high in DNA, intermediate in cellular viral RNA, and low in virion RNA

  2009cited by this paper
• APOBEC3B deletion and risk of HIV-1 acquisition.

  2009cited by this paper
• RNA-Dependent Oligomerization of APOBEC3G Is Required for Restriction of HIV-1

  2009cited by this paper
• Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development.

  2009cited by this paper
• Guidelines for Naming Nonprimate APOBEC3 Genes and Proteins

  2008cited by this paper
• Two Regions within the Amino-Terminal Half of APOBEC3G Cooperate To Determine Cytoplasmic Localization

  2008cited by this paper
• The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements.

  2008cited by this paper
• Retrovirology BioMed Central Review HIV-1 Vif, APOBEC, and Intrinsic Immunity

  2008cited by this paper
• Interactions of Murine APOBEC3 and Human APOBEC3G with Murine Leukemia Viruses

  2008cited by this paper
• Human Immunodeficiency Virus Type 1 Vif Functionally Interacts with Diverse APOBEC3 Cytidine Deaminases and Moves with Them between Cytoplasmic Sites of mRNA Metabolism

  2007cited by this paper
• DNA deamination in immunity: AID in the context of its APOBEC relatives.

  2007cited by this paper
• APOBEC3G Multimers Are Recruited to the Plasma Membrane for Packaging into Human Immunodeficiency Virus Type 1 Virus-Like Particles in an RNA-Dependent Process Requiring the NC Basic Linker

  2007cited by this paper
• Identification of Two Distinct Human Immunodeficiency Virus Type 1 Vif Determinants Critical for Interactions with Human APOBEC3G and APOBEC3F

  2007cited by this paper
• The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains.

  2007cited by this paper
• Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid

  2007cited by this paper
• Human Immunodeficiency Virus Type 1 cDNAs Produced in the Presence of APOBEC3G Exhibit Defects in Plus-Strand DNA Transfer and Integration

  2007cited by this paper
• APOBEC3B and APOBEC3F Inhibit L1 Retrotransposition by a DNA Deamination-independent Mechanism*

  2006influential reference
• Role and Mechanism of Action of the APOBEC3 Family of Antiretroviral Resistance Factors

  2006cited by this paper
• APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells

  2006influential reference
• Reversed Functional Organization of Mouse and Human APOBEC3 Cytidine Deaminase Domains*

  2006cited by this paper
• Identification of APOBEC3DE as Another Antiretroviral Factor from the Human APOBEC Family

  2006cited by this paper
• Cellular inhibitors of long interspersed element 1 and Alu retrotransposition.

  2006cited by this paper
• Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases.

  2005cited by this paper
• Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity.

  2005cited by this paper
• APOBEC3G targets human T-cell leukemia virus type 1

  2005cited by this paper
• Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif.

  2005cited by this paper
• Complementary function of the two catalytic domains of APOBEC3G.

  2005cited by this paper
• Regulated Production and Anti-HIV Type 1 Activities of Cytidine Deaminases APOBEC3B, 3F, and 3G

  2005cited by this paper
• Differential Sensitivity of Murine Leukemia Virus to APOBEC3-Mediated Inhibition Is Governed by Virion Exclusion

  2005cited by this paper
• Cytidine deamination of retroviral DNA by diverse APOBEC proteins.

  2004influential reference
• APOBEC3B and APOBEC3C Are Potent Inhibitors of Simian Immunodeficiency Virus Replication*

  2004cited by this paper
• Retroviral restriction by APOBEC proteins

  2004cited by this paper
• APOBEC3G Is Incorporated into Virus-like Particles by a Direct Interaction with HIV-1 Gag Nucleocapsid Protein*

  2004cited by this paper
• Ancient Adaptive Evolution of the Primate Antiviral DNA-Editing Enzyme APOBEC3G

  2004cited by this paper
• DNA deamination mediates innate immunity to retroviral infection.

  2003cited by this paper
• Human Immunodeficiency Virus Type 1 N-Terminal Capsid Mutants That Exhibit Aberrant Core Morphology and Are Blocked in Initiation of Reverse Transcription in Infected Cells

  2001cited by this paper
• Reversion of a Human Immunodeficiency Virus Type 1 Matrix Mutation Affecting Gag Membrane Binding, Endogenous Reverse Transcriptase Activity, and Virus Infectivity

  1999cited by this paper
• High frequency retrotransposition in cultured mammalian cells.

  1996cited by this paper
• An indicator gene to demonstrate intracellular transposition of defective retroviruses.

  1988cited by this paper

• RNase H-sensitive accumulation of APOBEC3B in a nucleolus after DNA damage

  2025cites this paper
• Development of APOBEC3B inhibitors: Recent advances and perspectives.

  2025cites this paper
• Regulatory Interactions between APOBEC3B N- and C-Terminal Domains

  2025cites this paper
• APOBEC3D excludes APOBEC3F from HIV-1 virions by competitive binding of RNA

  2024cites this paper
• Regulatory interactions between APOBEC3B N- and C-terminal domains

  2024cites this paper
• Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations

  2024cites this paper
• APOBEC3B Is Co-Expressed with PKCα/NF-κB in Oral and Oropharyngeal Squamous Cell Carcinomas

  2023cites this paper
• Evolutionary potential of the monkeypox genome arising from interactions with human APOBEC3 enzymes

  2023cites this paper
• Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations

  2023cites this paper
• Evolutionary potential of the monkeypox genome arising from interactions with human APOBEC3 enzymes

  2023cites this paper
• Human cytomegalovirus mediates APOBEC3B relocalization early during infection through a ribonucleotide reductase-independent mechanism

  2023cites this paper
• Multiple roles of apolipoprotein B mRNA editing enzyme catalytic subunit 3B (APOBEC3B) in human tumors: a pan-cancer analysis

  2022cites this paper
• Ancestral APOBEC3B Nuclear Localization Is Maintained in Humans and Apes and Altered in Most Other Old World Primate Species

  2022cites this paper
• Identification of natural product 3, 5-diiodotyrosine as APOBEC3B inhibitor to prevent somatic mutation accumulation and cancer progression

  2022cites this paper
• Research on the influence of APOBEC family on the occurrence, diagnosis, and treatment of various tumors

  2022cites this paper
• The current toolbox for APOBEC drug discovery.

  2022cites this paper
• Examination of the APOBEC3 Barrier to Cross Species Transmission of Primate Lentiviruses

  2021cites this paper
• Factors Regulating the Activity of LINE1 Retrotransposons

  2021cites this paper
• APOBEC3-induced mutation of the hepatitis virus B DNA genome occurs during its viral RNA reverse transcription into (−)-DNA

  2021cites this paper
• Targeting natural splicing plasticity of APOBEC3B restricts its expression and mutagenic activity

  2021cites this paper
• Isoform-specific characterization implicates alternative splicing in APOBEC3B as a mechanism restricting APOBEC-mediated mutagenesis

  2020cites this paper
• [APOBEC3s: history of an antiviral and mutagenic protein family].

  2020cites this paper
• Altered T-Lymphocyte Biology Following High-Dose Melphalan and Autologous Stem Cell Transplantation With Implications for Adoptive T-Cell Therapy

  2020cites this paper
• Characterization of the mechanism by which the RB/E2F pathway controls expression of the cancer genomic DNA deaminase APOBEC3B

  2020cites this paper
• APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy

  2020cites this paper
• The DNA deaminase APOBEC3B interacts with the cell-cycle protein CDK4 and disrupts CDK4-mediated nuclear import of Cyclin D1

  2019cites this paper
• Evolutionary effects of the AID/APOBEC family of mutagenic enzymes on human gamma-herpesviruses

  2019cites this paper
• APOBEC3s: DNA‐editing human cytidine deaminases

  2019cites this paper
• Contribution of cytosine desaminases of AID/APOBEC family to carcinogenesis

  2019cites this paper
• The spectrum of APOBEC3 activity: From anti-viral agents to anti-cancer opportunities.

  2019cites this paper
• APOBEC3B edits HBV DNA and inhibits HBV replication during reverse transcription

  2018cites this paper
• Investigating the Structural Basis for Human Disease: APOBEC3A and Profilin

  2018cites this paper
• Human APOBEC3B interacts with the heterogenous nuclear ribonucleoprotein A3 in cancer cells

  2018cites this paper
• Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature

  2018cites this paper
• APOBEC3 Mediates Resistance to Oncolytic Viral Therapy

  2018cites this paper
• Determinants of Oligonucleotide Selectivity of APOBEC3B

  2018cites this paper
• APOBEC3B Nuclear Localization Requires Two Distinct N-Terminal Domain Surfaces.

  2018influential citation
• Conformational Switch Regulates the DNA Cytosine Deaminase Activity of Human APOBEC3B

  2017cites this paper
• Heat shock proteins stimulate APOBEC-3–mediated cytidine deamination in the hepatitis B virus

  2017cites this paper
• Association of Hepatitis B Virus Covalently Closed Circular DNA and Human APOBEC3B in Hepatitis B Virus-Related Hepatocellular Carcinoma

  2016cites this paper
• Evidence for APOBEC3B mRNA and protein expression in oral squamous cell carcinomas.

  2016cites this paper
• Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity.

  2016cites this paper
• CDK11 in TREX/THOC Regulates HIV mRNA 3' End Processing.

  2015cites this paper
• DNA cytosine and methylcytosine deamination by APOBEC3B: enhancing methylcytosine deamination by engineering APOBEC3B

  2015cites this paper
• Crystal Structure of the DNA Deaminase APOBEC3B Catalytic Domain*

  2015cites this paper
• Suppression of APOBEC3-mediated restriction of HIV-1 by Vif

  2014cites this paper
• A computational analysis of the structural determinants of APOBEC3's catalytic activity and vulnerability to HIV-1 Vif.

  2014cites this paper
• APOBEC3G exerts tumor suppressive effects in human hepatocellular carcinoma

  2014cites this paper
• Different Mutagenic Potential of HIV-1 Restriction Factors APOBEC3G and APOBEC3F Is Determined by Distinct Single-Stranded DNA Scanning Mechanisms

  2014cites this paper
• Lack of Association between Intact/Deletion Polymorphisms of the APOBEC3B Gene and HIV-1 Risk

  2014cites this paper
• Human LINE-1 restriction by APOBEC3C is deaminase independent and mediated by an ORF1p interaction that affects LINE reverse transcriptase activity

  2013cites this paper
• Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma.

  2013cites this paper
• The APOBEC3 family of retroelement restriction factors.

  2013cites this paper
• Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination

  2013cites this paper
• APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma.

  2013cites this paper
• Retroelements versus APOBEC3 family members: No great escape from the magnificent seven

  2012cites this paper
• APOBEC3B and AID have similar nuclear import mechanisms.

  2012cites this paper
• The role of the rhesus macaque (macaca mulatta) apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3) in lentiviral replication and persistence

  2012cites this paper
• Endogenous APOBEC3B Restricts LINE-1 Retrotransposition in Transformed Cells and Human Embryonic Stem Cells*

  2011cites this paper